Most cited papers from Quanterix (United States)

Quanterix (United States)

What are the most cited papers from Quanterix (United States)?

The most cited paper from Quanterix (United States) is "Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations" (David M. Rissin, Cheuk Wai Kan, Todd G. Campbell et al., 2010), with 2,150 citations. Next come "Plasma β-amyloid in Alzheimer’s disease and vascular disease" (635) and "Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study" (623).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 60 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations David M. Rissin, Cheuk Wai Kan, Todd G. Campbell et al. · Nature Biotechnology Open access	23 May 2010	2,150
2	Plasma β-amyloid in Alzheimer’s disease and vascular disease Shorena Janelidze, Erik Stomrud, Sebastian Palmqvist et al. · Scientific Reports Open access	31 May 2016	635
3	Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study Elisabeth H. Thijssen et al. · The Lancet Neurology Open access	18 Aug 2021	623
4	Systems vaccinology of the BNT162b2 mRNA vaccine in humans Prabhu S. Arunachalam et al. · Nature Open access	12 Jul 2021	598
5	Teaching Tips: A Guidebook for the Beginning College Teacher Wilbert J. McKeachie	1969	532
6	Plasma tau in Alzheimer disease Niklas Mattsson, Henrik Zetterberg, Shorena Janelidze et al. · Neurology Open access	30 Sep 2016	522
7	The Simoa HD-1 Analyzer: A Novel Fully Automated Digital Immunoassay Analyzer with Single-Molecule Sensitivity and Multiplexing David H. Wilson, David M. Rissin, Cheuk Wai Kan et al. · SLAS TECHNOLOGY Open access	15 Jun 2015	489
8	Plasma tau levels in Alzheimer's disease Henrik Zetterberg, David H. Wilson, Ulf Andréasson et al. · Alzheimer s Research & Therapy Open access	2013	399
9	Blood Biomarkers for Brain Injury in Concussed Professional Ice Hockey Players Pashtun Shahim, Yelverton Tegner, David H. WILSON et al. · JAMA Neurology	13 Mar 2014	397
10	Blood‐based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic Sid E. O’Bryant et al. · Alzheimer s & Dementia Open access	18 Nov 2016	317
11	The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer’s disease Sarah C. Hopp, Yang Lin, Derek H. Oakley et al. · Journal of Neuroinflammation Open access	18 Sep 2018	303
12	Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease Suzanne Elizabeth Schindler et al. · Nature Reviews Neurology ReviewOpen access	12 Jun 2024	296
13	Guidelines for the standardization of preanalytic variables for blood‐based biomarker studies in Alzheimer's disease research Sid E. O’Bryant et al. · Alzheimer s & Dementia Open access	30 Sep 2014	293
14	Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes Michelle M. Mielke, Ryan D. Frank, Jeffrey L. Dage et al. · JAMA Neurology Open access	26 Jul 2021	263
15	Simultaneous Detection of Single Molecules and Singulated Ensembles of Molecules Enables Immunoassays with Broad Dynamic Range David M. Rissin, David R. Fournier, Tomasz Piech et al. · Analytical Chemistry Open access	23 Feb 2011	262
16	Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19 Benjamin Krämer et al. · Immunity Open access163 authors	4 Sep 2021	260
17	Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group Inge M.W. Verberk et al. · Alzheimer s & Dementia Open access	29 Nov 2021	251
18	Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: Results of a pilot study Jeffrey Randall, Erik Mörtberg, Gail K. Provuncher et al. · Resuscitation	9 Aug 2012	232
19	Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury Tanya Bogoslovsky, David H. Wilson, Yao Chen et al. · Journal of Neurotrauma Open access	16 Jun 2016	218
20	Single molecule enzyme-linked immunosorbent assays: Theoretical considerations Lei Chang, David M. Rissin, David R. Fournier et al. · Journal of Immunological Methods Open access	20 Feb 2012	192
21	Hypoxia Due to Cardiac Arrest Induces a Time-Dependent Increase in Serum Amyloid β Levels in Humans Henrik Zetterberg, Erik Mörtberg, Linan Song et al. · PLoS ONE Open access	14 Dec 2011	174
22	Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases Alberto Lleó, Enrica Cavedo, Lucilla Parnetti et al. · Nature Reviews Neurology Review	16 Dec 2014	167
23	Glial fibrillary acidic protein elevations relate to neuroimaging abnormalities after mild TBI Jessica Gill, Lawrence L. Latour, Ramon R. Diaz-Arrastia et al. · Neurology Open access	12 Sep 2018	161
24	Multiplexed single molecule immunoassays David M. Rissin, Cheuk Wai Kan, Linan Song et al. · Lab on a Chip Open access	2013	161
25	Peripheral Total Tau in Military Personnel Who Sustain Traumatic Brain Injuries During Deployment Anlys Olivera, Natasha Lejbman, Andreas Jeromin et al. · JAMA Neurology	3 Aug 2015	160
26	N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection Dandan Shan et al. · Nature Communications Open access	26 Mar 2021	143
27	A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis David Devos, Caroline Moreau, Maéva Kyheng et al. · Scientific Reports Open access	27 Feb 2019	139
28	Olympic boxing is associated with elevated levels of the neuronal protein tau in plasma Sanna Neselius, Henrik Zetterberg, Kaj Blennow et al. · Brain Injury	8 Mar 2013	133
29	Learnings about the complexity of extracellular tau aid development of a blood‐based screen for Alzheimer's disease Zhicheng Chen, David Mengel, Ashvini Keshavan et al. · Alzheimer s & Dementia Open access	9 Nov 2018	124
30	Isolation and detection of single molecules on paramagnetic beads using sequential fluid flows in microfabricated polymer array assemblies Cheuk Wai Kan, Andrew J. Rivnak, Todd G. Campbell et al. · Lab on a Chip	16 Dec 2011	124
31	Stochastic inhibitor release and binding from single-enzyme molecules Hans H. Gorris, David M. Rissin, David R. Walt · Proceedings of the National Academy of Sciences Open access	26 Oct 2007	121
32	Acute plasma tau relates to prolonged return to play after concussion Jessica Gill, Kian Merchant‐Borna, Andreas Jeromin et al. · Neurology Open access	7 Jan 2017	114
33	Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration Julio C. Rojas et al. · Neurology Open access	7 Apr 2021	112
34	Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease Pia Kivisäkk, Becky Catherine Carlyle, Thadryan Sweeney et al. · Alzheimer s Research & Therapy Open access	23 Apr 2022	106
35	Plasma Glial Fibrillary Acidic Protein in the Alzheimer Disease Continuum: Relationship to Other Biomarkers, Differential Diagnosis, and Prediction of Clinical Progression Xue‐Ning Shen, Shu‐Yi Huang, Mei Cui et al. · Clinical Chemistry Open access	2 Mar 2023	105
36	Digital enzyme-linked immunosorbent assays with sub-attomolar detection limits based on low numbers of capture beads combined with high efficiency bead analysis Cheuk Wai Kan, Carmen I. Tobos, David M. Rissin et al. · Lab on a Chip	2020	104
37	Repetitive head impact exposure and later‐life plasma total tau in former National Football League players Michael Louis Alosco, Yorghos Tripodis, Johnny Jarnagin et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring Open access	9 Dec 2016	101
38	A fully-automated, six-plex single molecule immunoassay for measuring cytokines in blood Andrew J. Rivnak, David M. Rissin, Cheuk Wai Kan et al. · Journal of Immunological Methods Open access	7 May 2015	101
39	Longitudinal assessment of white matter abnormalities following sports‐related concussion Timothy Bradley Meier, Maurizio Bergamino, Patrick S.F. Bellgowan et al. · Human Brain Mapping Open access	10 Dec 2015	100
40	Fluid Biomarkers of Traumatic Brain Injury and Intended Context of Use Tanya Bogoslovsky, Jessica Gill, Andreas Jeromin et al. · Diagnostics Open access	18 Oct 2016	98
41	Elevated tau and interleukin-6 concentrations in adults with obstructive sleep apnea Vida Motamedi, Rebekah Z. Kanefsky, Panagiotis Matsangas et al. · Sleep Medicine Open access	24 Nov 2017	92
42	Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia Elisabeth H. Thijssen, Inge M.W. Verberk, Jana Kindermans et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring Open access	2022	91
43	Direct Detection of Bacterial Genomic DNA at Sub-Femtomolar Concentrations Using Single Molecule Arrays Linan Song, Dandan Shan, Mingwei Zhao et al. · Analytical Chemistry	18 Jan 2013	89
44	A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1–42 peptide in human plasma with utility for studies of Alzheimer’s disease therapeutics Linan Song, David Richard Lachno, David Hanlon et al. · Alzheimer s Research & Therapy Open access	Dec 2016	86
45	Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative Brice Laurens, Radu Constantinescu, Roy L. Freeman et al. · Neurobiology of Disease Open access	15 May 2015	86
46	Performance Evaluation of a Multiplex Assay for Simultaneous Detection of Four Clinically Relevant Traumatic Brain Injury Biomarkers Frederick Kofi Korley, John K. Yue, David H. Wilson et al. · Journal of Neurotrauma Open access	25 Apr 2018	85
47	Correlation of Blood Biomarkers and Biomarker Panels with Traumatic Findings on Computed Tomography after Traumatic Brain Injury Jussi P. Posti et al. · Journal of Neurotrauma Open access	2019	84
48	CSF and Plasma Amyloid-β Temporal Profiles and Relationships with Neurological Status and Mortality after Severe Traumatic Brain Injury Stefania Mondello, András Büki, Pál Barzó et al. · Scientific Reports Open access	10 Oct 2014	82
49	Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab Boris Gorovits, Daniel J. Baltrukonis, Indranil Bhattacharya et al. · Clinical & Experimental Immunology Open access	12 Feb 2018	81
50	Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development Darshana Jani, John L. Allinson, Flora Berisha et al. · The AAPS Journal Open access	16 Sep 2015	77

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.